Influence of Hormone Therapy on Heart Attack Incidence in Men Undergoing Prostate Brachytherapy

Completed

• Conditions: Prostate Cancer; Cardiovascular Death

• Registration Number: NCT00651222
• Lead Sponsor: Prostate Cancer Foundation of Chicago

Brief Summary

The purpose of this study is to review cause of death in patients undergoing prostate brachytherapy at a single institution. Furthermore, we are analyzing patients undergoing androgen deprivation therapy and whether or not this contributed to cardiovascular deaths, specifically myocardial infarction.

Detailed Description

Not available

Study Timeline

• Status Verified: 2008-03
• Study First Submitted: 2008-03-31
• Study First Submitted QC: 2008-03-31
• Last Update Submitted: 2008-03-31
• Study First Posted: 2008-04-02
• Last Update Posted: 2008-04-02

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Male
• Target Recruitment: Not specified

Inclusion Criteria

• Deceased anytime after prostate brachytherapy treatment

Exclusion Criteria

• Patients whose cause of death was unable to be determined

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

Chicago Prostate Center; 🇺🇸 Westmont, Illinois, United States